CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.

NCT07742839 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Edwards Lifesciences